Tag

NASDAQ: LUCD

Lucid Diagnostics announces 11,991‑patient EsoGuard study publication
Adrian Kessler · Nov 3, 2026
Lucid Diagnostics joins Russell 2000 and 3000 indexes
Joseph Morton · May 28, 2025